Elevated levels of oxidized low-density lipoprotein and impaired nocturnal synthesis of melatonin in patients with myocardial infarction

Atherosclerosis

Volumn 180, Issue 1, 2005, Pages 101-105

  Dominguez Rodriguez, A ^a   Abreu Gonzalez, P ^b   Garcia Gonzalez, M ^a   Ferrer Hita, J ^a   Vargas, M ^a   Reiter, R J ^c  

^a HOSPITAL UNIVERSITARIO DE CANARIAS   (Spain)

^b UNIVERSIDAD DE LA LAGUNA   (Spain)

^c UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

Ischemia; Melatonin; Myocardial infarction; Oxidized LDL; Oxygen radicals

Indexed keywords

CHLOROFORM; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; MELATONIN; MONOCLONAL ANTIBODY; OXIDIZED LOW DENSITY LIPOPROTEIN;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; ATHEROSCLEROSIS; COMPARATIVE STUDY; CONTROLLED STUDY; CORRELATION ANALYSIS; ENZYME IMMUNOASSAY; ENZYME LINKED IMMUNOSORBENT ASSAY; EXTRACTION; FEMALE; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HORMONE BLOOD LEVEL; HORMONE SYNTHESIS; HUMAN; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; OXIDATION KINETICS; PRIORITY JOURNAL; STATISTICAL ANALYSIS;

EID: 17044423329     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2004.11.003     Document Type: Article

References (41)

1. U. Landmesser, and D.G. Harrison Oxidant stress as a marker for cardiovascular events: Ox marks the spot Circulation 104 2001 2638 2640
2. J.L. Witztum, and D. Steinberg The oxidative modification hypothesis of atherosclerosis: does it hold for humans? Trends Cardiovasc Med 11 2001 93 102
3. D. Steinberg, S. Parthasarathy, T.E. Carew, J.C. Khoo, and J.L. Witztum Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity N Engl J Med 320 1989 915 924
4. R.J. Reiter Pineal melatonin. Cell biology of its synthesis and of its physiological interactions Endocr Rev 12 1991 151 180
5. R. Zaidan, M. Geoffriau, and J. Brun Melatonin able to influence its secretion in humans: description of a phase-response curve Neuroendocrinology 60 1994 105 112
6. R.J. Reiter, and D.X. Tan Melatonin: a novel protective agent against oxidative injury of the ischemic/reperfused heart Cardiovasc Res 58 2003 10 19
7. P. Brugger, W. Marktl, and M. Herold Impaired nocturnal secretion of melatonin in coronary artery disease Lancet 345 1995 1408
8. A. Sakotnik, P.M. Liebmann, and K. Stoschitzky Decreased melatonin synthesis in patients with coronary artery disease Eur Heart J 20 1999 1314 1317
9. W. Marktl, P. Brugger, and M. Herold Melatonin and coronary heart disease Wien Klin Wochenschr 109 1997 747 749
10. D.X. Tan, L.D. Chen, B. Poeggeler, L.C. Manchester, and R.J. Reiter Melatonin: a potent, endogenous hydroxyl radical scavenger Endocr J 1 1993 57 60
11. C. Pieri, M. Marra, F. Moroni, R. Recchioni, and F. Marcheselli Melatonin: a peroxyl radical scavenger more effective than Vitamin E Life Sci 55 1994 PL271 PL276
12. M. Allegra, R.J. Reiter, and D.X. Tan The chemistry of melatonin's interaction with reactive species J Pineal Res 34 2003 1 10
13. R.J. Reiter, D.X. Tan, and B. Poeggeler Melatonin as a free radical sacavenger: implications for aging and age-related diseases Ann NY Acad Sci 719 1994 1 12
14. C. Pieri, M. Marra, R. Gaspar, and S. Damjanovich Melatonin protects LDL from oxidation but does not prevent the apolipoprotein derivatization Biochem Biophys Res Commun 222 1996 256 260
15. M.R. Kelly, and G. Loo Melatonin inhibits oxidative modification of human low-density lipoprotein J Pineal Res 22 1997 203 209
16. H. Seegar, A.O. Mueck, and T.H. Lippert Effect of melatonin and metabolites on copper-mediated oxidation of low density lipoprotein Br J Clin Pharmacol 44 1997 283 284
17. M.C. Cohen, K.M. Rothla, C.L. Lavery, J.E. Muller, and M.A. Mittleman Meta-analysis of the morning excess of acute myocardial infarction and sudden cardiac death Am J Cardiol 79 1997 1512 1516
18. Myocardial infarction redefined-a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction J Am Coll Cardiol 36 2000 959 969
19. T. Weinbrenner, M. Cladellas, and M. Isabel Covas High oxidative stress in patients with stable coronary heart disease Atherosclerosis 168 2003 99 106
20. P. Holvoet, J. Vanhaeke, S. Janssens, F. Van de Werf, and D. Collen Oxidized LDL and malondialdehyde-modified LDL in patients with acute coronary syndromes and stable coronary artery disease Circulation 15 1998 1487 1494
21. D. Steinberg Low density lipoprotein oxidation and its pathobiological significance J Biol Chem 272 1997 20963 20966
22. S. Tsimikas, and J.L. Witztum Measuring circulating oxidized low-density lipoprotein to evaluate coronary risk Circulation 103 2001 1930 1932
23. S. Ehara, M. Ueda, and T. Naruko Elevated levels of oxidized low density lipoprotein show a positive relationship with severity of acute coronary syndromes Circulation 103 2001 1955 1960
24. P. Holvoet, D. Collen, and F. van de Werf Malondialdehyde-modified LDL as marker of acute coronary syndromes JAMA 281 1999 1718 1721
25. P. Holvoet, A. Mertens, and P. Verhamme Circulating oxidized LDL is a useful marker for identifying patients with coronary artery disease Arterioscler Thromb Vasc Biol 21 2001 844 848
26. M. Yaprak, A. Altun, and A. Vardar Decreased nocturnal síntesis of melatonin in patients with coronary artery disease Int J Cardiol 89 2003 103 107
27. L. Girotti, M. Lago, and O. Ianovsky Low urinary 6-sulphatoxymelatonin levels in patients with coronary artery disease J Pineal Res 29 2000 138 142
28. A. Altun, M. Yaprak, and M. Aktoz Impaired nocturnal síntesis of melatonin in patients with cardiac síndrome X Neurosci Lett 327 2002 143 145
29. A. Dominguez-Rodriguez, P. Abreu-Gonzalez, and M.J. Garcia Decreased nocturnal melatonin levels during acute myocardial infarction J Pineal Res 33 2002 248 252
30. H. Esterbauer, G. Striegl, and H. Puhl The role of Vitamin E and carotenoids in preventing oxidation of low density lipoproteins Ann NY Acad Sci 570 1989 254 267
31. A.V. Babiy, J.M. Gebicki, and D.R. Sullivan Vitamin E content and low density lipoprotein oxidizability induced by free radicals Atherosclerosis 81 1990 175 182
32. T.Y. Chan, and P.L. Tang Effect of melatonin on the maintenance of cholesterol homeostasis in the rat Endocr Res 21 1995 681 696
33. D. Muller-Wieland, B. Behnke, K. Koopmann, and W. Krone Melatonin inhibits LDL receptor activity and cholesterol synthesis in freshly isolated human mononuclear leukocytes Biochem Biophys Res Commun 203 1994 416 421
34. P. Stasica, P. Ulanski, and J.M. Rosiak Melatonin as a hydroxil radical scavenger J Pineal Res 25 1998 65 66
35. S. Cuzzocrea, B. Zingarelli, and E. Gilad Protective effect of melatonin in carrageenan-induced models of local inflammation: relationship to its inhibitory effect on nitric oxide production and its peroxynitrite scavenging activity J Pineal Res 23 1997 106 116
36. H. Esterbauer, J. Gebicki, H. Puhl, and G. Jurgens The role of lipid peroxidation and antioxidants in oxidative modification of LDL Free Radic Biol Med 13 1992 341 390
37. P. Holvoet, and D. Collen Oxidized lipoproteins in atherosclerosis and thrombosis FASEB J 8 1994 1279 1284
38. D. Bonnefont-Rousselot, G. Cheve, and A. Gozzo Melatonin related compounds inhibit lipid peroxidation during copper or free radical-induced LDL oxidation J Pineal Res 33 2002 109 117
39. R.J. Reiter, D.X. Tan, L.C. Manchester, and M.R. El-Sawi Melatonin reduces oxidant damage and promotes mitochondrial respiration: implications for aging Ann NY Acad Sci 959 2002 238 250
40. D. Acuña-Castroviejo, M. Martin, and M. Macias Melatonin, mitochondria and cellular bioenergetics J Pineal Res 30 2001 65 74
41. J. Leon, D. Acuña-Castroviejo, and R.M. Sainz Melatonin and mitochondrial function Life Sci 75 2004 765 790